Physician profile
Anita M Juriga
NPI 1841277597
$1,450.99
in general payments reported to CMS, 2019-2025
11 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Medical-Surgical (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $692 · 2022: $207 · 2023: $281 · 2024: $151 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $597.42 | 2021-2025 | Camzyos |
| Abbott Laboratories | $303.37 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $181.04 | 2021 | |
| Janssen Pharmaceuticals, INC | $142.62 | 2021 | |
| Novartis Pharmaceuticals Corporation | $61.73 | 2021 | |
| Boston Scientific Corporation | $55.54 | 2021 | |
| Preventice Services, LLC | $36.32 | 2021 | |
| Alnylam Pharmaceuticals INC. | $26.85 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.81 | 2021-2023 | Lifevest |
| Amarin Pharma, INC. | $15.40 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Juriga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.